Sphere Fluidics announced the launch of Cyto-Cellect® PLUS, a fluorescence resonance energy transfer (FRET) assay to enable researchers to quantify IgG productivity with high sensitivity. The new assay expands on the company’s original Cyto-Cellect Human IgGκ Detection Kit by now detecting both the IgG κ and λ light chains to support a broader range of projects. The company claims the assay is fully compatible with existing Cyto-Mine® functionality, including single-cell dispensing into 96-well and 384-well plates, allowing it to seamlessly integrate into customers’ existing cell line development workflows. The company adds that the assay conforms to relevant regulatory requirements by being animal origin free.
